A Study to Evaluate a New Jaundice Stick Test
Bilistick
Field Evaluation of a Point-Of-Care Test for Serum Bilirubin Levels in Infants Born in a Tropical Limited-resource Setting.
1 other identifier
observational
180
1 country
1
Brief Summary
This is an observational prospective study. The main purpose is to evaluate the stability of the Bilistick system in a humid and hot climate compared to the quantitative test for serum bilirubin (SBR) measurement currently used, the BR-501 total bilirubin meter, kept in a controlled environment. The secondary aim is to assess the operational feasibility of the Bilistick system in a tropical limited-resource setting, when used by locally trained nurses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2016
CompletedFirst Posted
Study publicly available on registry
October 6, 2016
CompletedStudy Start
First participant enrolled
January 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 11, 2017
CompletedOctober 2, 2018
July 1, 2018
11 months
September 22, 2016
October 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Comparison of the agreement of serum bilirubin measurement between the two tests in three different seasons
The main outcome of interest is the potential effect of environmental conditions on the quantitative outcome of the Bilistick System, using BR-501 bilirubin meter machine as a reference. The Bland-Altman analysis will be used to compare the two tests.
18 months
Within each season, evaluation of the impact of temporal variation on the agreement of serum bilirubin measurement between the two tests.
A linear regression analysis will be done to look for statistically significant effect of exposure time on the difference between the average total bilirubin serum levels of the two tests.
18 months
Secondary Outcomes (2)
Evaluation of the usability of the Bilistick system using a 5-point likert scale questionnaire and a focus group discussions
18 months
Perception by the trained nurses of the Bilistick system usability with a focus group discussion (FGD).
18 months
Study Arms (1)
Infants
Infants requiring serum bilirubin (SBR) measurement seen in Wang Pha clinic (WPA) clinic.
Interventions
* One full capillary tube (50µl blood) will be used to measure the Hct level and the routine SBR using the BR-501 bilirubin meter machine (non-study procedure). * An additional half- filled capillary tube (25µl blood) will be used for the SBR measurement with the Bilistick system
Eligibility Criteria
Infant seen in WPA clinic during the neonatal period (birth to 28 days of life).
You may qualify if:
- Written or thumb print for informed consent from the parent
- Infant born ≥ 35 weeks of gestational age
- Infant who needs a routine SBR measurement
- Infant in stable clinical condition prior to SBR measurement confirmed by the trained nurses
You may not qualify if:
- The participant will not be enrolled in the study if ANY of the following applies:
- Infant who already had 1 SBR measurement done with the Bilistick system
- Last haematocrit measurement \> 65% or no previous haematocrit measurement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- Shoklo Malaria Research Unitcollaborator
Study Sites (1)
Shoklo Malaria Research Unit (SMRU)
Mae Sot, Changwat Tak, 63110, Thailand
Biospecimen
Blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Professor Rose McGready, MD
Shoklo Malaria Research Unit (SMRU)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2016
First Posted
October 6, 2016
Study Start
January 25, 2017
Primary Completion
December 11, 2017
Study Completion
December 11, 2017
Last Updated
October 2, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share